Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
Tao Liu, Xiang Wan, Zhizhuang Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 16

Showing 16 citing articles:

Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies
Meng‐Di Zhang, Haiying Qiu, Zheyi Han, et al.
International Journal of Pharmaceutics X (2025) Vol. 9, pp. 100316-100316
Closed Access
Celastrol Elicits Antitumor Effects through Inducing Immunogenic Cell Death and Downregulating PD-L1 in ccRCC
Hongfang Li, Neng Zhu, Jiajun Wu, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 16, pp. 1265-1278
Closed Access | Times Cited: 4
Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma
Matteo Santoni, Veronica Mollica, Alessandro Rizzo, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102881-102881
Closed Access
TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study
Aimin Jiang, Ying Liu, Ziwei He, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 4, pp. 382-394
Open Access | Times Cited: 2
TAF1D promotes tumorigenesis and metastasis by activating PI3K/AKT/mTOR signaling in clear cell renal cell carcinoma
Xuan Hu, Liang Chen, Tao Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111425-111425
Open Access | Times Cited: 2
Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning
Dazhi Lu, Yan Zheng, Jianye Hao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer
Gavin Frame, Hon S. Leong, Roni Haas, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
An Exogenous Ketone Ester Slows Tumor Progression in Murine Breast and Renal Cancer Models
Henry Nnaemeka Ogbonna, Zachary Roberts, Nicholas Godwin, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3390-3390
Open Access | Times Cited: 1
Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster
Nader H. Mahmoudzadeh, Yasaman Heidarian, Jason P. Tourigny, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group
Nam P. Nguyen, Monica-Emilia Chirilă, B.R. Page, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Comprehensive investigation of malignant epithelial cell-related genes in clear cell renal cell carcinoma: development of a prognostic signature and exploration of tumor microenvironment interactions
Songyang Liu, Ge Li, Xiaomao Yin, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster
Nader H. Mahmoudzadeh, Yasaman Heidarian, Jason P. Tourigny, et al.
Molecular Metabolism (2024) Vol. 89, pp. 102013-102013
Open Access
The PLOD2 promotes tumor progression in colorectal cancer through the PI3K-AKT pathway
Denghong Chen, Mili Zhang, Yuxuan Zhou, et al.
(2024)
Closed Access
E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production
Liang Chen, Xuan Hu, Gang Wang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 82, Iss. 1
Open Access
Designing lysyl hydroxylase inhibitors for oral submucous fibrosis — Insights from molecular dynamics
N.R. Kandasamy, Thamilselvi Palanivel, Selvaraj Vimalraj, et al.
International Journal of Biological Macromolecules (2024), pp. 139304-139304
Closed Access
HIFs in hypoxic regulation of the extracellular matrix: focus on little-known player HIF-3
А. Н. Горностаева, Л. Б. Буравкова, M. V. Lobanova, et al.
Biocell (2024) Vol. 48, Iss. 5, pp. 677-692
Open Access
Page 1

Scroll to top